Company: ARMP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001558370-25-007765
Chunk: 22

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 6
Chunk 22
---
ated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K, filed with the SEC on December 11, 2019).​​​3.10​Amendment to Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on February 26, 2020). ​​​4.1​Reference is made to Exhibits 3.1 through 3.10.​​​10.1​Credit and Security Agreement, dated March 12, 2025, by and among the Company and Innoviva Strategic Opportunities, LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on March 12, 2025).